Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients
Fig 4
Prognostic Nomograms for patients with TNBC to predict OS and DFS.
(a and b). Nomograms predict the OS and DFS of patients with TNBC via the clinicopathological characteristics and pretreatment serum cancer biomarkers. The Harrell’s c-indexes of the OS and DFS evaluation were 0.664 (95% CI: 0.613–0.714) and 0.673 (95% CI: 0.626–0.720), respectively. (c and d). Calibration graphs for the 5-year OS and DFS are shown. The x-axis represents the nomogram-forecasted chance of survival, and the y-axis represents the survival rate. The imaginary line is diagonal and shows ideal matching.